Raymond James Downgrades Sagent Pharmaceuticals (SGNT) to Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. TMUS
9. SPY
10. SBUX

Go back to Raymond James Downgrades Sagent Pharmaceuticals (SGNT) to Market Perform

Nichi-Iko Pharmaceutical Co., Ltd to Acquire Sagent Pharmaceuticals for $21.75 Per Share in All Cash Transaction

July 11, 2016 2:30 AM EDT

Transaction brings together two market leaders in generics with highly complementary product offerings

Marks a significant step in Nichi-Ikos international growth strategy through establishment of U.S. platform

TOKYO & SCHAUMBURG, Ill.--(BUSINESS WIRE)-- Nichi-Iko Pharmaceutical Co., Ltd (TSE: 4541) and Sagent Pharmaceuticals, Inc. (NASDAQ: SGNT) today announced that they have entered into a definitive merger agreement under which Nichi-Iko will acquire Sagent via an all-cash tender offer (the Tender Offer) followed by a second-step merger, for a total... More